Posts by tag
Sarah Cannon Research Institute
HCA Healthcare forms consortium with AHRQ and research institutions to accelerate COVID-19 research
HCA Healthcare is proud to announce that we’ve formed a consortium of prominent public and private research institutions to use HCA Healthcare’s vast data on COVID-19 hospital care to improve patient outcomes and public knowledge. The institutions – including the federal Agency for Health Research and Quality (AHRQ), Johns Hopkins University, Duke University, Meharry Medical…
172 HCA Healthcare hospitals join COVID-19 convalescent plasma study
In continuing our efforts to fight the COVID-19 pandemic, HCA Healthcare is taking part in a national study where recovered COVID-19 patients can donate plasma to potentially help critically-ill patients. We are leveraging our clinical research capabilities and national hospital network to improve COVID-19 patient care and outcomes. Today, we announced that 172 HCA Healthcare…
World Cancer Day: we are fighting cancer together
Did you know 1 in 2 men and 1 in 3 women will be diagnosed with cancer in their lifetime? But, there is good news on the horizon. According to the American Cancer Society, new figures are promising, citing a 27% decline in United States cancer death rates since 1991. Sarah Cannon, the Cancer Institute…
January is Cervical Cancer Awareness Month: Sarah Cannon shares what you need to know
January is Cervical Cancer Awareness Month, a time to raise awareness around risk factors and treatments for cervical cancer. It is also a time to celebrate that the mortality rate for cervical cancer has dropped by 50% in the past 40 years, which is attributed to the widespread use of Pap smears. “But this doesn’t…
- Cancer
- Clinical
- HCA Healthcare
- Hospitals
- MidAmerica
- Sarah Cannon
- Sarah Cannon Research Institute
- Women's Health
Breast cancer breakthrough: Sarah Cannon discusses newly FDA-approved immunotherapy
Spring brings new hope and new beginnings, and for breakthroughs in cancer treatment, this season is off to a promising start. Earlier this month, the U.S. Food and Drug Administration (FDA) approved the first-ever immunotherapy (atezolizumab), in combination with chemotherapy, for the treatment of breast cancer. “Immunotherapy is a drug that we’ve been using in…
Sarah Cannon Shares how to Talk to Your Kids About a Cancer Diagnosis
Being diagnosed with cancer can be overwhelming – as you learn new terminology, create a treatment plan with your care team and adjust your daily life to new appointments and physical challenges. Talking to your kids about your diagnosis is an added layer to this journey. Sarah Cannon, the cancer institute of HCA, provides resources…